Arkania, E., Makharadze, T., Kunta, G., Melkadze, T., Baramidze, A., Spira, A. I., Paz-Ares, L. G., Girard, N., Park, J. S., Ghattas, M., Li, Y., Li, S., Salvati, M., Lowy, I., Fury, M. G., Paoluzzi, L. (2025). Phase 2 peri-operative study of fianlimab + cemiplimab + chemotherapy versus cemiplimab + chemotherapy in resectable early-stage non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8117